Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
出版年份 2018 全文链接
标题
Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer
作者
关键词
-
出版物
BRITISH JOURNAL OF CANCER
Volume 118, Issue 4, Pages 462-470
出版商
Springer Nature
发表日期
2018-01-19
DOI
10.1038/bjc.2017.428
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Phosphatidylinositol 3-Kinase Inhibition by Copanlisib in Relapsed or Refractory Indolent Lymphoma
- (2017) Martin Dreyling et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas
- (2016) A. Patnaik et al. ANNALS OF ONCOLOGY
- Biliary cancer: Utility of next-generation sequencing for clinical management
- (2016) Milind Javle et al. CANCER
- American Society for Clinical Pharmacology and Therapeutics
- (2016) CLINICAL PHARMACOLOGY & THERAPEUTICS
- The E545K mutation of PIK3CA promotes gallbladder carcinoma progression through enhanced binding to EGFR
- (2016) Shuai Zhao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma
- (2016) Xiaoman Li et al. Oncotarget
- Current Status on Cholangiocarcinoma and Gallbladder Cancer
- (2016) Tomoki Ebata et al. Liver Cancer
- The PTEN tumor suppressor gene and its role in lymphoma pathogenesis
- (2015) Xiaoxiao Wang et al. Aging-US
- Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
- (2015) Shikha Satendra Singh WORLD JOURNAL OF GASTROENTEROLOGY
- Effects of PTEN gene alteration in patients with gallbladder cancer
- (2015) Asgar Ali et al. Cancer Genetics
- Mutational profiling reveals PIK3CA mutations in gallbladder carcinoma
- (2013) Vikram Deshpande et al. BMC CANCER
- BAY 80-6946 Is a Highly Selective Intravenous PI3K Inhibitor with Potent p110α and p110δ Activities in Tumor Cell Lines and Xenograft Models
- (2013) Ningshu Liu et al. MOLECULAR CANCER THERAPEUTICS
- Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
- (2010) Juan Valle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Take your PIK: phosphatidylinositol 3-kinase inhibitors race through the clinic and toward cancer therapy
- (2009) N. T. Ihle et al. MOLECULAR CANCER THERAPEUTICS
- PI3K pathway alterations in cancer: variations on a theme
- (2008) T L Yuan et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search